Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.55 HKD
Change Today +0.01 / 0.65%
Volume 2.0M
As of 4:01 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

tianjin teda biomedical-h (8189) Snapshot

Open
$1.50
Previous Close
$1.54
Day High
$1.55
Day Low
$1.37
52 Week High
04/28/15 - $1.80
52 Week Low
11/10/14 - $0.56
Market Cap
2.5B
Average Volume 10 Days
1.2M
EPS TTM
$0.01
Shares Outstanding
897.5M
EX-Date
--
P/E TM
108.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for TIANJIN TEDA BIOMEDICAL-H (8189)

Related News

No related news articles were found.

tianjin teda biomedical-h (8189) Related Businessweek News

No Related Businessweek News Found

tianjin teda biomedical-h (8189) Details

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, is engaged in the research, development, manufacture, and sale of biological compound fertilizer products and health care products in the People’s Republic of China. It operates in two segments, Compound Fertilizers Products and Health Care Products. The company markets its biological compound fertilizer products under the Fulilong brand, which are used for the balanced growth of grains, fruits, and vegetables. It also offers a series of health care products under the Alpha brand comprising diabetic health care products and related products with the function of regulating the blood sugar level; and various sugar-free products, including beverages, low glucose cookies, cereals, calcium-rich milk powder, and mooncakes. The company was founded in 2000 and is headquartered in Tianjin, the People's Republic of China.

500 Employees
Last Reported Date: 03/27/15
Founded in 2000

tianjin teda biomedical-h (8189) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: CNY485.6K
Vice Chairman
Total Annual Compensation: CNY447.2K
Company Secretary
Total Annual Compensation: CNY150.0K
Compensation as of Fiscal Year 2013.

tianjin teda biomedical-h (8189) Key Developments

Tianjin TEDA Biomedical Engineering Company Limited Announces Consolidated Unaudited Earnings Results for the First Quarter Ended March 31, 2015

Tianjin TEDA Biomedical Engineering Company Limited announced consolidated unaudited earnings results for the first quarter ended March 31, 2015. For the three months ended 31 March 2015, the Group achieved a consolidated turnover of RMB 130,181,487, representing a decrease of 4.9% as compared to the same period of last year (31 March 2014: RMB 136,906,003). In particular, the Group recorded a sales turnover of RMB 108,672,424 for compound fertilizer products, representing a decrease of 7.7% as compared to the same period of last year (31 March 2014: RMB 117,722,388); the Group recorded a sales turnover of RMB 21,509,063 for health care products, representing an increase of 12.1% as compared to the same period of last year (31 March 2014: RMB 19,183,615). For the quarter, the company reported loss before tax was RMB 77,194 compared with profit before tax of RMB 4,148,387 for the same period a year ago. Profit attributable to owners of the parent company was RMB 2,651,479 or 0.187 cents per basic share compared with RMB 4,157,162 or 0.293 cents per basic share for the same period a year ago.

Tianjin TEDA Biomedical Engineering Company Limited Appoints Guan Tong as the Chairman of the Audit Committee

Tianjin TEDA Biomedical Engineering Company Limited announced that Mr. Guan Tong has been appointed as the chairman of the Audit committee due to his professional qualifications in accounting and auditing experience.

Tianjin TEDA Biomedical Engineering Company Limited, Annual General Meeting, May 21, 2015

Tianjin TEDA Biomedical Engineering Company Limited, Annual General Meeting, May 21, 2015., at 09:30 China Standard Time. Location: 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th Avenue, TEDA. Agenda: To consider and, if thought fit, approve the audited consolidated financial statement of the group for the year ended 31 December 2014; to consider and, if thought fit, approve the report of the directors of the company; to consider and, if thought fit, approve the report of the Supervisory Committee of the company; and to consider and, if thought fit, approve the proposal of appointing BDO Limited as auditor of the company for the financial year of 2015 and authorize the Directors of the company to fix their remuneration.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8189:HK $1.55 HKD +0.01

8189 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8189.
View Industry Companies
 

Industry Analysis

8189

Industry Average

Valuation 8189 Industry Range
Price/Earnings 100.0x
Price/Sales 3.2x
Price/Book 8.8x
Price/Cash Flow 120.5x
TEV/Sales 3.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN TEDA BIOMEDICAL-H, please visit www.bioteda.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.